Pharma Journalist -

Exelixis, Inc. and Invenra, Inc. announced that they have expanded their discovery and licensing collaboration to include an additional 20 oncology targets. The augmented partnership…
Read More...

InnoCare, a leading biopharmaceutical company focusing on drug innovation for cancer and autoimmune diseases, announced the first subject dosed in clinical trial of novel TYK2 (Tyrosine…
Read More...

Over the last 2 decades, scientists and drug developers have been puzzled yet fascinated by Wnt/β-Catenin – its role in maintaining cancer stem cells, regulating numerous gene…
Read More...

Moderna, Inc. a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, announced the publication of new data on the durability of the Moderna COVID-19 vaccine…
Read More...

Nimbus Therapeutics, a biotechnology company designing breakthrough medicines through structure-based drug discovery and development, announced the extension of its collaboration with…
Read More...

Artiva Biotherapeutics, Inc. (“Artiva”), an oncology company focused on developing and commercializing primary allogeneic natural killer (NK) cell therapies to treat cancer, announced…
Read More...

ProBioGen is pleased to announce that Nobelpharma has signed a license agreement for the use of the AGE1.CR.pIX vaccine production platform to develop their lead vaccine. The signing of…
Read More...

Sheba Medical Center at Tel Hashomer, the largest hospital in the Middle East region, and Lonza, a leading global cell and gene therapy manufacturer, announced today that they have…
Read More...

Precision NanoSystems (PNI), a global leader in innovative solutions for genetic medicine development, will expand its global headquarters with a 75,000-square-foot facility currently…
Read More...

Have you secured your FREE pass to the 𝐆𝐚𝐬𝐭𝐫𝐨𝐢𝐧𝐭𝐞𝐬𝐭𝐢𝐧𝐚𝐥 𝐂𝐚𝐧𝐜𝐞𝐫 𝐃𝐫𝐮𝐠 𝐃𝐞𝐯𝐞𝐥𝐨𝐩𝐦𝐞𝐧𝐭 𝐒𝐮𝐦𝐦𝐢𝐭 yet? It’s free-to-attend for drug developers, research, institutions and not-for-profit…
Read More...